Cancer prevalence set to treble

August 21, 2012
Cancer prevalence set to treble

(Medical Xpress) -- The number of older people (aged 65 and over) living with cancer in the UK is set to more than treble by 2040 – from 1.3 million in 2010 to 4.1 million – according to a new study by King’s College London researchers.

The Macmillan-funded study, published in The British Journal of , shows nearly one in four (23 per cent) will have had a cancer diagnosis in 2040 – almost double the proportion in 2010 (13 per cent). This is nearly four times the proportion for people aged 45-64.

Lung cancer prevalence in older women will see the biggest increase. The prevalence of lung cancer in older women will more than double from in 2010 to 2040 (from 319 to 831 per 100, 000), whereas lung cancer prevalence in older men is expected to decrease. This is due to a dramatic decline in smoking among men in England since the 1970s.

The sharp rise in cancer prevalence is likely to be due to a number of reasons including the ageing population, increasing incidence and increasing cancer survival.

Professor Henrik Møller, one of the study authors at King’s, says: ‘The aim of this research is to provide long term projections of cancer prevalence in the UK. The research shows that large increases can be expected in the oldest age groups in the coming decades and with this an increased demand upon health services.’

Currently older face a multitude of barriers to getting the best care and . These include under treatment, a lack of practical support at home preventing them from going to hospital to get treatment and poor management of non-cancer related health problems.

Ciarán Devane, Chief Executive at Macmillan Cancer Support, said: ‘The care of older cancer patients is the ticking time bomb for society. These stark predictions should act as a warning to the NHS and social care providers of the problems ahead if older cancer patients are not offered the best treatment and support.

‘We have a moral duty to give people the best chance of beating cancer, regardless of their age. For cancer survival to improve, older people must be given the right treatment at the correct level of intensity, together with the practical support to enable them to take it up.

‘The barriers to older people getting treatment must be tackled. If we don’t get this right now many older people will be dying unnecessarily from cancer in the future.’

Macmillan is calling for a more effective way of assessing older people for treatment, more short-term practical support to enable them to take up recommended treatment and training for professionals working with older people within the NHS to promote age equality.

Macmillan, in partnership with Age UK and the Department of Health, has set up five pilots to test new models of older people’s care. They will report in December 2012.

Explore further: Age affects risk of being diagnosed with cancer at advanced stage

More information: Maddams J, Utley M and Møller H. 2012. 'Projections of cancer prevalence in the United Kingdom, 2010–2040'. British Journal of Cancer. www.nature.com/bjc/journal/vao … ull/bjc2012366a.html

Related Stories

Age affects risk of being diagnosed with cancer at advanced stage

March 2, 2012
Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.

Elderly breast cancer patients less likely to get surgery

June 17, 2011
(PhysOrg.com) -- University of Manchester researchers, working with colleagues in York, Leeds and Hull, looked at the records of more than 23,000 women with breast cancer diagnosed in the West Midlands, Yorkshire and North ...

Almost half of cancer survivors have ill health in later years

October 11, 2011
Forty-five per cent of cancer survivors in Northern Ireland suffer from physical and mental health problems years after their treatment has finished, according to new research from Macmillan Cancer Support and Queen's University ...

Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA

July 6, 2011
Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to research presented at the 14th World ...

Report estimates nearly 18 million cancer survivors in US by 2022

June 14, 2012
The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according to a first-ever report by the American Cancer Society in collaboration with the National ...

Recommended for you

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

September 25, 2017
A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing ...

Researchers identify gene variants linked to a high-risk children's cancer

September 25, 2017
Pediatric researchers investigating the childhood cancer neuroblastoma have identified common gene variants that raise the risk of an aggressive form of that disease. The discovery may assist doctors in better diagnosing ...

Prostaglandin E1 inhibits leukemia stem cells

September 25, 2017
Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.

Cancer vaccines need to target T cells that can persist in the long fight against cancer

September 25, 2017
Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

Lung cancer treatment could be having negative health effect on hearts

September 25, 2017
Radiotherapy treatment for lung cancer could have a negative effect on the health of your heart new research has found.

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.